Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAKORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAKENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAKENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAKNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAAORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAAENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAANUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.50ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.50ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.50NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.38.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.38.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-15680China
XBB.1.38.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N/AORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N/AENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N/AENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N/ANUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EE.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EE.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
DB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BW.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BW.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used